Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
Arcadia Biosciences Inc
NASDAQ RKDA
Data sourced from
and
and
Arcadia Biosciences Inc Long-Term Debt for the quarter ending March 31, 2024
Arcadia Biosciences Inc Long-Term Debt is NA for the quarter ending March 31, 2024. Long-Term Debt includes debt obligations with maturities beyond one year.
-
Arcadia Biosciences Inc Long-Term Debt for the quarter ending March 31, 2021 was USD 96.00 K, a -26.15% change year over year.
-
Arcadia Biosciences Inc Long-Term Debt for the quarter ending March 31, 2020 was USD 130.00 K, a -92.66% change year over year.
Don’t Miss A Beat
Looking to stay ahead of the competition and stay informed? Receive your daily dose of market news, trends, and analysis to kickstart your day and stay up-to-date.
NASDAQ: RKDA
| CEO | Ms. Pamela Haley |
| IPO Date | May 15, 2015 |
| Location | United States |
| Headquarters | 202 Cousteau Place, Davis, CA, United States, 95618 |
| Employees | 21 |
| Sector | Consumer Defensive |
| Industry | Packaged foods |
Description
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Key trends
Similar companies
Seneca Foods Corp A
NA
NA
Bridgford Foods Corporation
NA
NA
StockViz Staff
September 16, 2024
Any question? Send us an email